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Abstract
Background: Amblyopia and amblyogenic factors like strabismus and refractive errors are the
most common vision disorders in children. Although different studies suggest that preschool vision
screening is associated with a reduced prevalence rate of amblyopia, the value of these programmes
is the subject of a continuing scientific and health policy discussion. Therefore, this systematic
review focuses on the question of whether screening for amblyopia in children up to the age of six
years leads to better vision outcomes.
Methods:  Ten bibliographic databases were searched for randomised controlled trials, non-
randomised controlled trials and cohort studies with no limitations to a specific year of publication
and language. The searches were supplemented by handsearching the bibliographies of included
studies and reviews to identify articles not captured through our main search strategy.
Results: Five studies met the inclusion criteria. Of these, three studies suggested that screening is
associated with an absolute reduction in the prevalence of amblyopia between 0.9% and 1.6%
(relative reduction: between 45% and 62%). However, the studies showed weaknesses, limiting the
validity and reliability of their findings. The main limitation was that studies with significant results
considered only a proportion of the originally recruited children in their analysis. On the other
hand, retrospective sample size calculation indicated that the power based on the cohort size was
not sufficient to detect small changes between the groups. Outcome parameters such as quality of
life or adverse effects of screening have not been adequately investigated in the literature currently
available.
Conclusion: Population based preschool vision screening programmes cannot be sufficiently
assessed by the literature currently available. However, it is most likely that the present systematic
review contains the most detailed description of the main limitations in current available literature
evaluating these programmes. Therefore, future research work should be guided by the findings of
this publication.
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Background
Amblyopia is a reversible visual deficit that develops dur-
ing the maturation of the visual system (which is usually
considered to be up to seven years of age) and may affect
one or both eyes [1-3]. Risk factors associated with ambly-
opia are strabismus (a misalignment of the eyes) and
uncorrected refractive errors, in particular anisometropia
(unequal refractive errors between the two eyes) [4,5].
Congenital cataract, congenital ptosis and corneal injury
or dystrophy can also cause amblyopia but are less com-
mon [6]. In Western countries, the prevalence rate of
amblyopia among preschool children ranges between 2%
and 5%, depending on the threshold value of visual acuity
at a particular age [7-10]. In a multicenter study, it was
shown that anisometropia was the cause of amblyopia in
nearly 40% of children aged from three to under seven
years. Strabismus was seen in 38% and a combination of
anisometropia and strabismus was the etiology in 24% of
preschool children treated for amblyopia [11].
Amblyopia is the leading cause of monocular vision loss
in people aged between 20 and 70 years [12]. The lifetime
risk of bilateral visual impairment in people with ambly-
opia aged 55 years or over is nearly doubled by the pres-
ence of this visual deficit (18%) [13]. The projected risk of
vision loss affecting the non-amblyopic eye in individuals
in the UK was also investigated by Rahi et al 2002, but
they reported a much lower lifetime risk of bilateral visual
impairment (1.2%) [14]. Moreover, amblyopia may also
harm school performance and later adult self-image
[15,16].
Preschool screening programmes for amblyopia were
developed in response to experimental data in animals
which suggested that early treatment of conditions analo-
gous to human amblyopia is more effective than treat-
ment later in life [17]. In some countries – for example in
Sweden and Israel – these programmes have been well
established [18,19]. However, countries like USA, Can-
ada, Belgium and Switzerland have no standardised pre-
school vision screening programmes [19]. Although
different (cross-sectional) studies, in particular from Scan-
dinavian countries [20] and a newly released study from
Israel [18], suggest that preschool vision screening is asso-
ciated with a reduced prevalence rate of amblyopia, the
value of these programmes is subject of a continuing sci-
entific and health policy discussion [21]. For example, a
British review from the year 1997 has suggested that pre-
school vision screening should be discontinued, on the
grounds that there is insufficient evidence to justify it [22].
In contrast, the U.S. Preventive Services Task Force (USP-
STF) recommends screening to detect amblyopia, strabis-
mus and defects in visual acuity in children between three
and four years of age [23]. Others, however, have argued
that additional research is needed to ascertain the utility
of preschool vision screening programmes [24].
In view of these discrepancies, we conducted an assess-
ment according to criteria of the UK National Screening
Committee [25] to determine the effectiveness of a pre-
school vision screening programme.
Methods
Systematic literature search
We searched Medline (Ovid), Embase, CINAHL,
PSYCHinfo, Cochrane Central (CDSR, DARE, NHS EED,
HTA), PSYNDEXplus, Social SciSearch, GIN and Medion
from inception until December 2007. The search strategy
was based on combinations of medical subject headings
(MeSH) and keywords and was not restricted to specific
languages or years of publication. The search strategy used
in Medline (Ovid) is presented in Table 1. Search strate-
gies for other databases were modified to meet the
requirements of each database. However, the search algo-
rithm was similar. Although not the focus of this review,
the literature search also included terms associated with
organic eye disorders, diagnostic measurements and treat-
ment of amblyopia. The results of these searches will be
presented in separate systematic reviews. The searches
were supplemented by handsearching the bibliographies
of included studies and reviews. Additionally, enquiries
were sent to manufactures of screening instruments.
Study selection
Titles and abstracts were reviewed using specific inclusion
criteria (see below). Full papers of appropriate studies
were obtained for detailed evaluation. Authors of studies
were contacted if data were unclear or appeared incom-
plete.
All stages of study selection, data extraction and quality
assessment were done independently by two reviewers
(CS, RR, SL, RG or JK). Any disagreement during the selec-
tion, extraction, and assessment process were resolved by
discussion and consensus.
Inclusion criteria
Included were studies that focused on unselected children
from the general population up to the age of six years.
Studies which included children with specific diseases
(such as diabetes, dyslexia, deafness or congenital dis-
eases) and organic eye defects (such as congenital glau-
coma, cataract, retinoblastoma) were excluded. Table 2
shows detailed inclusion criteria.
Data extraction and quality assessment
For the evaluation of the included studies a modified
quality evaluation tool of the Center for Reviews and Dis-BMC Ophthalmology 2009, 9:3 http://www.biomedcentral.com/1471-2415/9/3
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Table 1: Search strategy in Medline (Ovid)
Search term Hits
1 exp CHILD/ 1129108
2 exp INFANT/ 692510
3 (baby or babies or newborn or neonat$).mp. 536032
4 exp schools/ 49523
5 exp CHILD-HEALTH-SERVICES/ 14438
6 exp CHILD-DAY-CARE-CENTERS/ 3371
7 (CHILD$ or ADOLESC$ or JUVENILE$ or MINOR$ or SCHOOL$ or KINDER-GARTEN$ or PRE?SCHOOL$ or NURSER$).ti. 529317
8 (CHILD$ or ADOLESC$ or JUVENILE$ or MINOR$ or SCHOOL$ or KINDER-GARTEN$ or PRE?SCHOOL$ or NURSER$).ab. 640000
9 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 2031820
10 exp strabismus/ 9863
11 exp amblyopia/ 4081
12 exp REFRACTIVE-ERRORS/ 17635
13 ((EYE$ or SIGHT$ or VI-SION$ or VISUAL$) adj4 (PROBLEM$ or DEFECT$ or IMPAIR$ or DEFICI$ or REDUC$)).mp. [mp = ti, ot, ab, nm, hw] 24836
14 (LAZY adj EYE$).mp. [mp = ti, ot, ab, nm, hw] 14
15 (AMBLYOPI$ or SQUINT$ or STRABISM$ or ANISO-METROPI$ or MYOPI$ or HYPERMETROPI$ or ASTIGMATI$ or AM-METROPI$ or 
HYPER-OPI$).mp. [mp = ti, ot, ab, nm, hw]
32219
16 cataract$.mp. 40130
17 microtropia.mp. 75
18 glaucoma.mp. 36328
19 retinoblastoma.mp. 14353
20 ((heredit$ or retinal or macular) and dystroph$).mp. 5741
21 refract$.mp. [mp = ti, ot, ab, nm, hw] 77398
22 exp vision, low/ 936
23 (SPECTACLES or GLASSES).mp. 4495
24 exp Cataract/ 16513
25 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 208688
26 (test or tests or testing).mp. 1383219
27 examination$.mp. 424043
28 ophthalmoscop$.mp. 9356BMC Ophthalmology 2009, 9:3 http://www.biomedcentral.com/1471-2415/9/3
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29 photoscreen$.mp. 95
30 (acuity or red reflex).mp. 46057
31 exp Vision Tests/or exp Visual Acuity/ 52117
32 exp Ophthalmoscopy/ 5116
33 (vision or visual).mp. 246181
34 (test$ or screen$).mp. 2011737
35 33 and 34 58712
36 (Hirschberg or Bruckner or motil$ or funduscop$ or cyclopleg$ or skiascop$).mp. [mp = ti, ot, ab, nm, hw] 67108
37 (Auto?refract$ or random?dot or stereoacuity or Snellen or Sheridan-Gardiner).mp. [mp = ti, ot, ab, nm, hw] 2475
38 (Cover?uncover or Alternate cover or Corneal reflex or PhotoScreener or Visiscreen).mp. [mp = ti, ot, ab, nm, hw] 330
39 (Retinomax or Suresight).mp. [mp = ti, ot, ab, nm, hw] 39
40 26 or 27 or 28 or 29 or 30 or 31 or 32 or 35 or 36 or 37 or 38 or 39 1844319
41 exp "Sensitivity and Specificity 211681
42 exp Diagnosis/ 3862053
43 diagnos$.mp. 1268941
44 sensitiv$.mp. 743123
45 predict$.mp. 485857
46 accura$.mp. 238100
47 41 or 42 or 43 or 44 or 45 or 46 5133424
48 9 and 25 and 40 and 47 9851
49 exp Contact Lenses/ 8117
50 exp Eyeglasses/ 4478
51 (refractive adj correct$).ti. 29
52 (refractive adj correct$).ab. 316
53 ((optic$ or vision$ or visual$ or filter$ or lens$ or glass$ or spectacle$) adj3 (occlusion or penali$ or patch$)).ti. 129
54 ((optic$ or vision$ or visual$ or filter$ or lens$ or glass$ or spectacle$) adj3 (occlusion or penali$ or patch$)).ab. 671
55 49 or 50 or 51 or 52 or 53 or 54 12865
56 exp clinical trials/ 190907
57 exp research design/ 212573
58 comparative study/or placebos.mp. 1341575
Table 1: Search strategy in Medline (Ovid) (Continued)BMC Ophthalmology 2009, 9:3 http://www.biomedcentral.com/1471-2415/9/3
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59 exp treatment outcome/ 283315
60 double-blind method/or single-blind method/ 98869
61 ((single or double or triple) adj blind$3).ti. 20568
62 ((single or double or triple) adj blind$3).ab. 78020
63 random$.ti. 56160
64 random$.ab. 364411
65 controlled clinical trial.pt. 73779
66 clinical trial.pt. 450604
67 (clinical adj trial$1).ti. 25698
68 (clinical adj trial$1).ab. 90789
69 (control$3 adj trial$1).ti. 15725
70 (control$3 adj trial$1).ab. 38465
71 randomized controlled trial.pt. 228874
72 exp RANDOM ALLOCATION/ 57826
73 exp PROSPECTIVE STUDIES/ 213531
74 exp Follow-Up Studies/ 332322
75 56 or 57 or 58 or 59 or 60 or 61 or 62 or 63 or 64 or 65 or 66 or 67 or 68 or 69 or 70 or 71 or 72 or 73 or 74 2474586
76 9 and 25 and 55 and 75 633
77 9 and 25 and 55 1765
78 screen$.mp. 287728
79 exp Neonatal Screening/ 3723
80 exp VISION TESTS/ 19699
81 exp MASS SCREENING/ 77069
82 78 or 79 or 80 or 81 309225
83 9 and 25 and 82 4644
84 48 or 76 or 83 10737
85 48 or 77 or 83 11540
86 (animals not human).sh. 4025575
87 85 not 86 11140
Table 1: Search strategy in Medline (Ovid) (Continued)BMC Ophthalmology 2009, 9:3 http://www.biomedcentral.com/1471-2415/9/3
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semination (CRD) was used [26]. Information on the
number and age of participants, intervention, sample size
planning, blinding of outcome assessor, group compara-
bility, confounding factors, transparency of patient flow,
definition of amblyopia and statistical significance of the
results was abstracted.
Statistical analysis
Based on the limitations of the included studies, no meta-
analysis or sensitivity-analysis could be performed. There-
fore, the results of this review are presented in a narrative
way.
Results
Results of search and selection process
After removing duplicate references the searches identi-
fied 25,944 citations (including potential relevant treat-
ment and diagnostic studies and studies evaluating
organic eye diseases). For the question of this review, 24
full text publications (21 studies) evaluating different
screening strategies were retrieved for further assessment.
Of these, 16 publications (16 studies) were excluded after
reading the full paper. Reasons for exclusion and full ref-
erence details are given (see Appendix 1).
Description of included studies
Five studies (eight publications [27-34]) met the a priori
defined inclusion criteria. Table 3 shows characteristics
and outcome measures of the included studies. The meth-
odological quality of the studies, the prevalence rate of
amblyopia and the significance of the results are summa-
rized in Table 4 and 5, respectively.
Two cohort studies [27,28] and one pseudo-randomised
controlled clinical trial [31,32] suggested that screening is
significantly associated with an absolute reduction in the
prevalence rate of amblyopia between 0.9% and 1.6%
(relative reduction: between 45% and 62%). Further-
more, in the retrospective cohort study of Eibschitz-Tsim-
honi et al 2000 [27] (the only study which compared
screening versus no screening without implementing a
current screening programme) it was observed that the
frequency of severe amblyopia (visual acuity ≤5/15) was
reduced by a factor 17 in the screening group (p < 0.001).
Williams 2002 [31,32] and 2003 [28] also reported that
mean visual acuity in the worse eye was better for children
who had been treated for amblyopia in the intervention
group than for similar children in the control group (0.15
versus 0.26 LogMAR p < 0.001; 0.14 versus 0.20 LogMAR
p = 0.002, respectively).
However, the reliability of these findings is limited by
methodological weaknesses of the studies. For example,
Eibschitz-Tsimhoni et al 2000 [27] excluded approxi-
mately 20% and Williams 2002 [31,32] approximately
45% of the originally recruited children in their analysis
without giving any reasons for exclusion. Williams 2003
[28] only presented children who took part at the final
assessment at the age of 7.5 years in their publication. Fur-
thermore, they showed by an "Intention-to-Screen" anal-
ysis that the improved outcome for individuals with
amblyopia diminished when considering all children
offered screening rather than only those who received it.
The retrospective cohort study from Bray et al 1996 [33]
also found a lack of effects on the prevalence rate of
amblyopia at the age of seven years using an "Intention-
to-Screen" approach. Despite the fact that orthoptic
screening detected more cases of amblyopia associated
with microtropia and anisometropia than screening by a
health visitor or GP.
The only randomised controlled clinical trial [34] did not
find a difference in the prevalence rate of amblyopia
between the groups. This study – the only one of the five
included studies – also reported a prevalence rate for stra-
bismus at the age of 6.5 years. However, the outcomes
were similar in both groups (3.3% [intervention group]
versus 3.8% [control group], p = 0.460, Chi2-Test, own
calculation).
No study conducted prospective sample size planning.
Bray et al 1996 [33] and Williams 2002 [31,32], however,
Table 2: Inclusion criteria
Population Children from the general population up to the age of six years
Intervention Comparison of screening versus no screening
or Comparison of different screening strategies
Type of study Randomised controlled trials
Non-randomised intervention studies
Controlled cohort studies
Outcome measurements Prevalence rate of amblyopia measured by visual acuity
Quality of life (e.g., psychosocial or emotional impairment, labelling, social isolation)
Cognitive and educational development
Adverse effects related to screeningBMC Ophthalmology 2009, 9:3 http://www.biomedcentral.com/1471-2415/9/3
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Table 3: Characteristics and outcome measures of the included studies
Reference Study Type Intervention, number 
(N) of recruited children 
and age at screening
Number of screened 
children
(% coverage)
Outcome
Orthoptic screening
(N = 1582, age: 2.5–3 years)
916 (58)
vs
Bray 199633 Retrospective cohort study Health visitor screening
(N = 2081, age: 2.5–3 years)
1665 (80) Prevalence of amblyopia at 
the age of 7 years
vs
GP screening
(N = 1701, age: 2.5–3 years)
1378 (81)
Screening
(N = 988, age: 1–2.5 years)
808 (82)
Eibschitz-Tsimhoni 
200027
(Israel)
Retrospective cohort study vs Prevalence of amblyopia and 
visual acuity in the worse 
seeing eye at the age of 8 
years
No screening
(N = 782)
Preschool screening
(N = 1347, age 3 years)
1132 (82)
vs
Rasmussen 200034
(Sweden)
Randomised controlled 
clinical trial No preschool screening
(N = 2146)
2097 (98)§ Prevalence of amblyopia and 
strabismus at the age of 6.5 
years
Both groups:
Current screening programme 
(age: 4 years)
Intensive screening
(N = 2029, age 
8,12,18,25,31,37 mos)
1408 (69)
vs
Williams 200231,32
(UK)
Pseudo-randomised* 
controlled clinical trial
Less intensive screening
(N = 1461, age 37 mos)
939 (64) Prevalence of amblyopia and 
visual acuity† in the worse 
seeing eye at the age of 7.5 
years
Both groups:
Current screening programme 
(age: 48–60 mos)
Preschool screening
(N = 1516‡, age 37 mos)
1019 (67)
vs
Williams 200328,29,30
(UK)
Prospective cohort study No preschool screening
(N = 5062‡)
5062 Prevalence of amblyopia and 
visual acuity† in the worse 
seeing eye at the age of 7.5 
years
Both groups:
Current screening programme
(age: 48–60 mos)
Psychosocial impairments
* Pseudorandomisation: last digit in day of mother's date of birth was used to assign children to the intervention group.
† Visual acuity of children treated with occlusion.
‡ Only children who took part at the final assessment (at the age of 7.5 years) were presented in the publication.
§Refers to the number of children who took part in the current screening programme.BMC Ophthalmology 2009, 9:3 http://www.biomedcentral.com/1471-2415/9/3
Page 8 of 12
(page number not for citation purposes)
showed by retrospective power calculation that the groups
had too little power to demonstrate effects [33] or that
only moderate effects could be detected [31,32].
The comparability of groups was not given in the cohort
study from Williams 2003 [28]. But results were almost
identical after adjustment for confounding factors. In the
remaining two studies without randomisation [33,27], it
was not specified whether factors which could be associ-
ated with the main outcome were equally distributed
between the groups.
One study [28] evaluated in two additional publications
[29,30] the psychological impact (bullying) which patch-
ing treatment or wearing glasses might have on children.
However, data were not interpretable because of an
unclear selection process. Therefore, the relevant ques-
tion, if such an association depends on the screening
model could not be answered. None of the included stud-
ies reported data on other patient-relevant outcome
parameters.
Discussion
Principal findings
Our systematic review identified a lack of rigorous con-
trolled studies examining the effectiveness of a preschool
vision screening programme. One of the main limitations
of the included studies was that positive effects disap-
peared when all recruited children were included in the
final analysis and not only the sample undergoing screen-
ing [28]. This finding confirms that coverage, like compli-
ance with follow-up [35,36], is an important mediator of
the effectiveness of a screening programme. For example,
in a retrospective cohort study, amblyopia has been found
to be as prevalent in screening defaulters as in attenders,
indicating that the efficacy of amblyopia detection – and
Table 4: Methodological quality of the included studies
Reference Prospective sample 
size planning
Blinding of 
outcome assessor
Comparability of 
groups
Consideration of 
confounding 
factors
Transparency of 
patient flow
Bray
199633
No* Not specified Not specified Not specified Yes||
Eibschitz-Tsimhoni
200027
No Not specified Not specified# Not specified No
82% of the originally 
recruited children 
were included in the 
analysis**
Rasmussen
200034
No No Not specified No Yes||
Williams
200231,32
No† Yes Yes Yes§ No
about 55% of the 
originally recruited 
children (equally 
distributed in both 
groups) were included 
in the analysis††
Williams
200328,29,30
No* Yes No‡ Yes§ No
only children who took 
part at the final 
assessment were 
presented and analysed 
(62% of the originally 
recruited children)
* Retrospective power-analysis.
† Retrospective power-analysis for the outcome measure: visual acuity; prospective power-analysis for a not relevant endpoint.
‡ Parents of screened children were older, higher educated and smoked less during pregnancy; however, results were almost identical after 
adjustment for confounding factors.
§ For example: duration of breastfeeding, mother's educational level, 1st degree relative with squint, sex.
|| No children were excluded from the analysis.
# It was only noted that the two communities were similar in terms of race, social status, health care facilities, education, nutrition and climate.
** Unclear, if only children who attended the final assessment were analysed.
†† Only children who attended the final assessment were analysed.BMC Ophthalmology 2009, 9:3 http://www.biomedcentral.com/1471-2415/9/3
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hence the effectiveness of a preschool vision screening
programme at all – is highly dependent on its attendance
rate [37]. On the other hand, it is possible that the design
of the studies made it difficult to find differences between
the groups. Only one study compared screening versus no
screening [27]. In the remaining studies implemented
screening strategies – by means of current screening pro-
grammes in the control group – could also have had an
effect on the outcome measurement.
Beside methodological limitations, it is important to note
that the definition of amblyopia varied across studies.
These variations may also effect the outcome measure-
ments. For example, the study of Eibschitz-Tsimhoni
2000 [27] showed that the frequency of moderate ambly-
opia (visual acuity ≤5/10) was reduced by a factor of 2.5
in children in the screening group. In contrast, screened
children with severe amblyopia (visual acuity ≤5/15)
showed a prevalence of ambylopia which was reduced by
a factor of 17. Bray et al 1996 [33] who used one defini-
tion for amblyopia (cut-off visual acuity: 6/9) reported a
similar prevalence in all three cohorts. We do not know
whether there was a difference between the cohorts in
children with more severe amblyopia.
Measures such as school performance, cognitive impair-
ment and quality of life were not adequately evaluated in
the reviewed literature. However, concerns about bullying
exist [29] and may be a reason to complete treatment (eye
patching) prior to school entry.
Possible damaging effects of preschool screening
Our review has been unable to provide information on
the adverse effects of population based preschool vision
screening programmes. This is an important omission as
concerns about harm exists, particularly from disruption
of normal eye development [38], temporary loss of visual
acuity in the non-amblyopic eye [39] and costs associated
with further evaluation of children with false-positive
screening results [40].
The potential psychological impact on the child or its
family is also little explored. However, the frequency of
these possible damaging effects is primarily dependent on
the quality regulations and quality assurance measures in
a screening programme.
Strengths and weaknesses of this review
This review focused on the question of whether preschool
screening for amblyopia leads to better vision outcome.
Data on diagnostic test accuracy and the effectiveness of
interventions will be addressed in separate publications.
Extensive effort was invested to identify a wide spectrum
of published, unpublished and ongoing studies. We did
Table 5: Definition and prevalence rate of amblyopia
Reference Definition of amblyopia
(Snellen acuity)
Prevalence*
(Intervention group)
Prevalence* (Control group) P-value
Orthoptist Health Visitor
VA ≤6/9 1.1% (0.7–1.8%) 1.0% (0.6–1.5%) Not reported
Bray
199633
GP
1.2% (0.8–1.9%) Not reported
Eibschitz- Screening No screening
Tsimhoni VA ≤5/10 1.0% 2.6% <0.01
200027 VA ≤5/15 0.1% 1.7% <0.001
Rasmussen Preschool screening No preschool screening
200034 VA not specified 0.0% 0.1% Not reported
Williams Intensive screening Less intensive screening
200231,32 Inter-ocular difference ≥ 2 lines 1.5% 2.7% 0.06
VA <6/12 0.6% 1.8% 0.02
Williams Preschool screening No preschool screening
200328,29,30 Inter-ocular difference ≥ 2 lines 1.1% 2.0% 0.05 (0.24)†
VA ≤6/9 1.9% 3.4% 0.01 (0.16)†
VA <6/12 0.7% 1.3% 0.11 (0.55)†
VA = Visual acuity.
* In brackets: 95% confidence interval, if reported in the publication.
† Adjustment for confounding factors like sex, highest level of maternal education, birth weight, family history of strabismus/amblyopia and duration 
of breastfeeding.BMC Ophthalmology 2009, 9:3 http://www.biomedcentral.com/1471-2415/9/3
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not apply any language or date restriction. Furthermore,
only children from the general population were included
as they reflect the screening population. It is most likely
that this review contains the most detailed description of
the current available literature evaluating preschool vision
screening programmes.
Comparison with other systematic reviews
A Cochrane review from 2005 concluded that insufficient
evidence exists to determine the effectiveness of screening
programmes on the prevalence of amblyopia [41]. The
authors noted that no randomised controlled trials were
conducted in this area. An UK assessment from 1997 rec-
ommended that screening programmes should not be
implemented unless they have been evaluated because
there was no evidence found for the benefits of preschool
vision screening [22]. A French guideline from 2002 also
concluded that a national screening programme for vision
disorders cannot be recommended in view of the uncer-
tainties about the power of current screening programmes
[42]. In contrast, the USPSTF recommends screening to
detect amblyopia, strabismus and other defects in visual
acuity in children between three and four years [23]. Sim-
ilar to our review, the USPSTF found no direct evidence
that screening for visual impairment, compared with no
screening, leads to improved visual acuity. Their recom-
mendation is based on indirect evidence. For example,
they found that treatment of strabismus and amblyopia
can improve visual outcomes. In addition, they identified
no studies reporting harms resulting from screening, and
judged the potential for harms to be small. Therefore, the
USPSTF concluded that the benefits of screening are likely
to outweigh any potential negative effects. A newly
released Canadian Health Technology Assessment from
2007 also concluded that a preschool vision screening
programme meets most of the criteria to consider when
assessing a screening programme [43]. Still, they added
that additional research is needed to ascertain the utility
of national preschool vision screening in the Canadian
context.
Overall, the cited reviews agree that there is a lack of evi-
dence regarding preschool vision screening. However, the
available systematic assessments came to different conclu-
sions. This is most likely due to the fact that different
reviews applied different inclusion criteria (for example
some reviews also included studies with high-risk chil-
dren). But it also shows that when reviews are based
largely on observational rather than experimental data,
their interpretation is likely to be less straightforward.
Conclusion
The methodological weaknesses of the literature currently
available cannot be used to state that preschool vision
screening is not effective. But it shows that these pro-
grammes have not yet been tested in rigorously controlled
trials. Current recommendations should be targeted to
maximise coverage in established screening programmes.
In future research work screening studies should be devel-
oped to compare screened children with children who did
not undergo screening (ideally in randomised controlled
trials without the implementation of a current screening
programme in the control group). However, such a trial
might be difficult in particular of ethical reasons. There-
fore, different regions with and without screening – for
examples in countries like USA, Canada, Belgium, Ger-
many and Switzerland where no standardized preschool
vision screening programme is established – should be
compared using a controlled study design. Another possi-
bility for such a comparison would be to introduce screen-
ing programmes at different time points in different
regions (for example three to four year old children
should be compared with five to six year old children).
The present systematic review also showed that prospec-
tive sample size planning should be conducted in such
studies. Furthermore bullying and other psychosocial fac-
tors should form part of the outcome assessments of
screening programmes for amblyopia.
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References of excluded studies and reasons for exclu-
sion after reading the full paper
Atkinson J, Braddick O: Population vision screening and
individual visual assessment. Doc Ophthalmol Proc Series
1986, 45:376.
Reason for exclusion: no relevant outcome measurements.
Donahue SP, Baker JD, Scott WE, Rychwalski P, Neely DE,
Tong P, et al: Lions Clubs International Foundation
Core For Photoscreening: results from 17 programs and
400,000 preschool children.  Journal of AAPOS 2006,
10:44–8.BMC Ophthalmology 2009, 9:3 http://www.biomedcentral.com/1471-2415/9/3
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Reason for exclusion: no relevant outcome measurements.
Hard AL: Results of vision screening of 6-year-olds at
school: a population-based study with emphasis on
screening limits. Acta Ophthalmol Scand 2007; 85:415–8.
Reason for exclusion: no comparison of different screening
strategies.
Hard AL, Sjodell L, Borres MP, Zetterberg I, Sjostrand J.
Preschool vision screening in a Swedish city region:
results after alteration of criteria for referral to eye clin-
ics. Acta Ophthalmol Scand 2002, 80:608–11.
Reason for exclusion: no relevant outcome measurements.
Jarvis SN, Tamhne RC, Thompson L, Francis PM, Ander-
son J, Colver AF: Preschool vision screening. Arch Dis
Child 1991, 66:288–94.
Reason for exclusion: no relevant outcome measurements.
Juttmann RE, Van der Maas PJ, Lantau VK, Simonsz HJ, De
Faber JTN, Van der Werf-De Koning CM, et al: The Rotter-
dam Amblyopia Screening Effectiveness Study (RAM-
SES): Compliance and predictive value in the first 2
years. Br J Ophthalmol 2001, 85:1332–5. Reason for exclu-
sion: no comparison of different screening strategies.
Kemper AR, Clark SJ: Preschool Vision Screening by Family
Physicians. J Pediatr Ophthalmol Strabismus 2007, 44:24–7.
Reason for exclusion: no comparison of different screening
strategies.
Kemper AR, Uren RL, Clark SJ: Barriers to Follow-up Eye
Care After Preschool Vision Screening in the Primary
Care Setting: Findings From a Pilot Study. Journal of
AAPOS 2006, 10: 476–8.
Reason for exclusion: study type not eligible.
Kohler L, Stigmar G: Vision screening of four-year-old
children. Acta Paediatr Scand 1973, 62:17–27.
Reason for exclusion: no comparison of different screening
strategies.
Kvarnström G, Jakobsson P, Lennerstrand G: Screening
for visual and ocular disorders in children of the system
in Sweden. Acta Paediatr 1998, 87:1173–79.
Reason for exclusion: no comparison of different screening
strategies.
Macchiaverni FN, Jose NK, Rueda G: Ophthalmologic
screening of schoolchildren in Paulinia, Sao Paulo
(Brazil). Arq Bras Oftalmol 1979, 42: 289–94.
Reason for exclusion: selected group of children.
Morad Y, Bakshi E, Levin A, Binyamini OG, Zadok D, Avni
I, Dayan YB: Screening and Treating Amblyopia: Are We
Making a Difference? Invest Ophthalmol Vis Sci 2007,
48:2084–88.
Reason for exclusion: no comparison of different screening
strategies.
Nelson LB: Preschool vision screening by family physi-
cians. J Pediatr Ophthalmol Strabismus 2007, 44:12.
Reason for exclusion: study type not eligible.
Pampapathi MR, Cadman A: Screening for squints and
amblyopia in pre-school children in a service commu-
nity. J R Army Med Corps 1990, 136:153–5.
Reason for exclusion: no relevant outcome measurements.
Schaeffel F, Mathis U, Bruggemann G: Noncycloplegic
photorefractive screening in pre-school children with
the "PowerRefractor" in a pediatric practice. Optom Vis
Sci 2007, 84:630–9.
Reason for exclusion: no comparison of different screening
strategies.
Zaba JN, Reynolds W, Mozlin R, Costich J, Slavova S,
Steele GT: Comparing the effectiveness of vision screen-
ings as part of the school entrance physical examina-
tion to comprehensive vision examinations in children
ages 3 to 6: an exploratory study.  Optometry  2007,
10:514–22.
Reason for exclusion: selected group of children.
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